Kite Reports Fourth Quarter and Full Year 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St indexes climb after Fed's Waller says he could support rate hold
- Fed’s Waller open to September rate hold - if disinflation holds up
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Nvidia to acquire AI platform Hugging Face in landmark $12.9B deal
- Tesla to unveil Cybercab Texas today, details are few
Kite Pharma (KITE) Resume Trading; Shares up 18%
February 28, 2017 10:26 AM ESTKite Pharma (NASDAQ: KITE) resumes trading and is up 18.8% following earlier positive data.
... MoreKite Pharma (KITE) to resume trading at 10:25AM ET
February 28, 2017 10:10 AM ESTKite Pharma (NASDAQ: KITE) to resume trading at 10:25AM ET following earlier data
... MoreKite Pharma (KITE) Tops Q4 EPS by 44c
February 28, 2017 8:02 AM ESTKite Pharma (NASDAQ: KITE) reported Q4 EPS of ($1.31), $0.44 better than the analyst estimate of ($1.75). Revenue for the quarter came in at $4.9 million versus the consensus estimate of $5.6 million.
2017 Financial Guidance
Kite expects full year 2017 net cash burn to be between $325 million and $340 million, which... More